Same Indication

Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan

Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between Methotrexate and Yttrium Y 90 Ibritumomab Tiuxetan.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Methotrexate β€” 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate β€” C20H22N8O5.

Molecular Weight: Methotrexate β€” 454.4400 g/mol.

Type: Methotrexate β€” Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan β€” Antibody.